Asempa, T. E., Kuti, J. L., Nascimento, J. C., Pope, S. J., Salerno, E. L., Troy, P. J., & Nicolau, D. P. (2023). Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects. Journal of antimicrobial chemotherapy, 78(3), 703-709. https://doi.org/10.1093/jac/dkac447
Chicago Style (17th ed.) CitationAsempa, Tomefa E., Joseph L. Kuti, Jeffrey C. Nascimento, Samuel J. Pope, Edward L. Salerno, Patrick J. Troy, and David P. Nicolau. "Bronchopulmonary Disposition of IV Cefepime/taniborbactam (2–0.5 G) Administered over 2 H in Healthy Adult Subjects." Journal of Antimicrobial Chemotherapy 78, no. 3 (2023): 703-709. https://doi.org/10.1093/jac/dkac447.
MLA (9th ed.) CitationAsempa, Tomefa E., et al. "Bronchopulmonary Disposition of IV Cefepime/taniborbactam (2–0.5 G) Administered over 2 H in Healthy Adult Subjects." Journal of Antimicrobial Chemotherapy, vol. 78, no. 3, 2023, pp. 703-709, https://doi.org/10.1093/jac/dkac447.